天然和合成化合物向食道状细胞癌中的ferroptosis:研究进展和潜在的应用
Nana Wu1, Guanhua Wang2, Jinnuo Wang1
1Department of Clinical Medicine, The First School of Clinical Medicine, Anhui Medical University, Hefei, Anhui, 230032, PR China.
European journal of medicinal chemistry
|December 5, 2025
概括
用天然和合成化合物向铁,一种依赖于铁的细胞死亡,显示出治疗食道状细胞癌 (ESCC) 的前景. 这种方法为预防和治疗这种侵袭性消化系统癌症提供了新的途径.
科学领域:
- 在瘤学瘤学.
- 细胞死亡机制 细胞死亡机制
- 药物发现 药物发现 药物发现
背景情况:
- 食道状细胞癌 (ESCC) 的发病率和死亡率很高,晚期通常表现为转移和耐药性.
- 对于ESCC的传统疗法受到晚期诊断和治疗耐药性的限制.
- 铁亡,一种与铁代谢相关的受调细胞死亡途径,提供了针对癌细胞的潜在治疗策略.
研究的目的:
- 审查铁亡的机制及其在食道状细胞癌中的作用.
- 要总结在ESCC细胞中诱导铁亡的天然和合成化合物.
- 讨论针对ESCC治疗和预防向铁亡的治疗潜力.
主要方法:
- 对现有关于铁灭机制的文献进行系统审查.
- 在食道状细胞癌的背景下研究铁亡的研究分析.
- 汇编了ESCC中向铁亡的自然和合成化合物的数据.
主要成果:
- 诱导铁亡是一种可行的策略,可以抑制ESCC细胞活性并改善预后.
- 各种天然和合成化合物在向ESCC中的铁亡途径方面表现出有效性.
- 通过ferroptosis调节瘤细胞存活是精确ESCC治疗的关键方向.
结论:
- 用生物活性化合物向铁化是一种有前途的治疗方法,用于食道状细胞癌.
- 药理学诱导铁灭症为开发有效的ESCC治疗提供了一种新的策略.
- 这次审查强调了铁亡作为预防和治疗ESCC的潜在目标.
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K